Oct 12, 2023 by James HalleyWhy Shares of ProKidney Were Dropping ThursdayTwo factors led to the stock's slide on Thursday.
Oct 11, 2023 by James HalleyWhy Shares of Ardelyx Were Down WednesdayThe company's hopes for approval of a drug to treat chronic kidney disease took a hit.
Oct 11, 2023 by James HalleyWhy Shares of Sharecare Are Soaring on WednesdayThe company's stock climbed after a proposal by a private equity firm to buy up available stock.
Oct 11, 2023 by James HalleyWhy Shares of Fresenius Medical Care Were Dropping on WednesdayPositive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius.
Oct 11, 2023 by James HalleyWhy Shares of Silk Road Medical Are Dropping WednesdayThe company's CEO stepped down and the company reduced top-line yearly guidance.
Oct 10, 2023 by James HalleyWhy Shares of 89bio Plummeted on TuesdaySo-so trial data for a competitor's NASH therapy candidate that is similar to 89bio's candidate spooked investors.
Oct 10, 2023 by James HalleyWhy Shares of Erasca Are Jumping TuesdayThe company's chairman and CEO bought more than $2.025 million worth of company stock.
Oct 10, 2023 by James HalleyWhy Shares of Ventyx Biosciences Are Dropping TuesdayInvestors were unimpressed by the company's trial results for an ulcerative colitis therapy.
Oct 10, 2023 by James HalleyWhy Shares of Lexicon Pharmaceuticals Are Up TuesdayExpress Scripts will give its clients access to Lexicon's first approved therapy.
Oct 9, 2023 by James HalleyWhy Shares of Scilex Are Up MondayAn analyst at H.C. Wainwright initiated coverage on the stock.
Oct 9, 2023 by James HalleyWhy Shares of Tango Therapeutics Are Dropping MondayAnother company's buyout helped drive up the price last week. This week, investors started out by selling the stock.
Oct 8, 2023 by James HalleyWhich Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.
Oct 7, 2023 by James HalleyIs Editas Stock a Buy Now?Shares of the gene-editing company are close to their 52-week lows. Does it make sense to buy the stock now?
Oct 6, 2023 by James HalleyWhy Shares of Agiliti Dropped This WeekThe company replaced its CEO with a former CEO early in the week.
Oct 6, 2023 by James HalleyWhy Shares of Cassava Sciences Soared This WeekCassava bounced back from hitting a 52-week low to start the week.
Oct 6, 2023 by James HalleyWhy Shares of Koninklijke Philips Are Falling on FridayThe FDA is requiring more testing regarding the company's recall of sleep apnea and respiratory products.
Oct 6, 2023 by James HalleyWhy Shares of Accolade Fell This WeekThe company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.
Oct 5, 2023 by James HalleyWhy Shares of uniQure Are Up ThursdayThe company announced a reorganization that included layoffs.
Oct 5, 2023 by James HalleyWhy Shares of MaxCyte Are Plummeting on ThursdayThe biotech company reduced full-year guidance and expects so-so third-quarter revenue.
Oct 5, 2023 by James Halley3 Top Pot Stocks to Watch in OctoberThree big multi-state operators that are strong enough to thrive for years.
